These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 221374)

  • 1. Effect of exogenous interferon on neonatal infection with murine cytomegalovirus.
    Cruz JM; Waner JL; Dammin GJ
    IARC Sci Publ (1971); 1978; (24 Pt 2):1067-71. PubMed ID: 221374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon as a defence mechanism in mouse cytomegalovirus infection.
    Chong KT; Gresser I; Mims CA
    J Gen Virol; 1983 Feb; 64 (Pt 2)():461-4. PubMed ID: 6187894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging and reactivation of latent murine cytomegalovirus.
    Schmader KE; Rahija R; Porter KR; Daley G; Hamilton JD
    J Infect Dis; 1992 Dec; 166(6):1403-7. PubMed ID: 1331252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interferons in the resistance to murine cytomegalovirus.
    Martinotti MG; Gariglio M; Cofano F; Cavallo G; Landolfo S
    Microbiologica; 1990 Oct; 13(4):305-9. PubMed ID: 1708083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.
    Tanaka K; Koga Y; Lu YY; Zhang XY; Wang Y; Kimura G; Nomoto K
    J Clin Invest; 1994 Sep; 94(3):1019-25. PubMed ID: 8083343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine cytomegalovirus (MCMV).
    Lussier G
    Adv Vet Sci Comp Med; 1975; 19():223-47. PubMed ID: 174412
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.
    Sandford GR; Burns WH
    J Infect Dis; 1988 Sep; 158(3):596-601. PubMed ID: 2842407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection.
    Cruz JR; Dammin GJ; Waner JL
    Infect Immun; 1981 Apr; 32(1):332-42. PubMed ID: 6163727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral infection-homograft interactions in a murine model.
    Hamilton JD; Fitzwilliam JF; Cheung KS; Shelburne J; Lang DJ; Amos DB
    J Clin Invest; 1978 Dec; 62(6):1303-12. PubMed ID: 219027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine cytomegalovirus gene amplification and culture after submaxillary salivary gland biopsy.
    Schmader KE; Rahija RJ; Porter KR; Hamilton JD
    Lab Anim Sci; 1991 Oct; 41(5):396-400. PubMed ID: 1666135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of mouse cytomegalovirus in organs of white mice experimentally infected by natural route.
    Svobodová J; Blaskovic D; Hucková D
    Acta Virol; 1986 Nov; 30(6):515-8. PubMed ID: 2881473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
    Jeitziner SM; Walton SM; Torti N; Oxenius A
    Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine models of cytomegalovirus-associated pneumonitis.
    Shanley JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):12-6, discussion 16. PubMed ID: 1648814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of murine cytomegalovirus ocular infection. Anterior chamber inoculation.
    Bale JF; O'Neil ME; Lyon B; Perlman S
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1575-81. PubMed ID: 2167300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression reactivates and disseminates latent murine cytomegalovirus.
    Jordan MC; Shanley JD; Stevens JG
    J Gen Virol; 1977 Nov; 37(2):419-23. PubMed ID: 200714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A focused salivary gland infection with attenuated MCMV: an animal model with prevention of pathology associated with systemic MCMV infection.
    Pilgrim MJ; Kasman L; Grewal J; Bruorton ME; Werner P; London L; London SD
    Exp Mol Pathol; 2007 Jun; 82(3):269-79. PubMed ID: 17320076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of host defense mechanisms by murine cytomegalovirus infection.
    Kelsey DK; Olsen GA; Overall JC; Glasgow LA
    Infect Immun; 1977 Dec; 18(3):754-60. PubMed ID: 201566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice.
    Shellam GR; Flexman JP; Farrell HE; Papadimitriou JM
    Scand J Immunol; 1985 Aug; 22(2):147-55. PubMed ID: 2412279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of ocular murine cytomegalovirus infection.
    Hayashi K; Kurihara I; Uchida Y
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):486-93. PubMed ID: 2984137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.